Horizon Therapeutics Public Ltd Co Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Horizon Therapeutics Public Ltd Co.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Horizon Therapeutics Public Ltd Co for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Sell | S | 21.26 | 2,000 | 42,520 | 28,867 | 30.9 K to 28.9 K (-6.48 %) |
| Feb 25 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Sell | S | 21.19 | 4,500 | 95,355 | 30,867 | 35.4 K to 30.9 K (-12.72 %) |
| Feb 25 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Sell | S | 21.20 | 3,580 | 75,896 | 35,367 | 38.9 K to 35.4 K (-9.19 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Option Exercise | M | 0.00 | 2,182 | 0 | 4,363 | |
| Feb 22 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Payment of Exercise | F | 21.24 | 1,082 | 22,982 | 30,596 | 31.7 K to 30.6 K (-3.42 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Buy | M | 0.00 | 2,182 | 0 | 31,678 | 29.5 K to 31.7 K (+7.40 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Payment of Exercise | F | 21.54 | 9,429 | 203,101 | 29,496 | 38.9 K to 29.5 K (-24.22 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Grant | A | 0.00 | 19,014 | 0 | 38,925 | 19.9 K to 38.9 K (+95.49 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Payment of Exercise | F | 21.54 | 8,425 | 181,475 | 107,857 | 116.3 K to 107.9 K (-7.25 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Grant | A | 0.00 | 19,014 | 0 | 116,282 | 97.3 K to 116.3 K (+19.55 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 21.54 | 8,622 | 185,718 | 62,863 | 71.5 K to 62.9 K (-12.06 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Grant | A | 0.00 | 19,014 | 0 | 71,485 | 52.5 K to 71.5 K (+36.24 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Payment of Exercise | F | 21.54 | 8,425 | 181,475 | 99,416 | 107.8 K to 99.4 K (-7.81 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Grant | A | 0.00 | 19,014 | 0 | 107,841 | 88.8 K to 107.8 K (+21.41 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Payment of Exercise | F | 21.54 | 4,179 | 90,016 | 38,947 | 43.1 K to 38.9 K (-9.69 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Grant | A | 0.00 | 14,259 | 0 | 43,126 | 28.9 K to 43.1 K (+49.40 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Konstantinovsky Irina | EVP, Chief Human Re ... | Payment of Exercise | F | 21.54 | 8,425 | 181,475 | 28,805 | 37.2 K to 28.8 K (-22.63 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Konstantinovsky Irina | EVP, Chief Human Re ... | Grant | A | 0.00 | 19,014 | 0 | 37,230 | 18.2 K to 37.2 K (+104.38 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Payment of Exercise | F | 21.54 | 15,795 | 340,224 | 47,531 | 63.3 K to 47.5 K (-24.94 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Grant | A | 0.00 | 35,652 | 0 | 63,326 | 27.7 K to 63.3 K (+128.83 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Payment of Exercise | F | 21.54 | 32,064 | 690,659 | 182,359 | 214.4 K to 182.4 K (-14.95 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Grant | A | 0.00 | 72,375 | 0 | 214,423 | 142 K to 214.4 K (+50.95 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 21.54 | 32,064 | 690,659 | 40,311 | 72.4 K to 40.3 K (-44.30 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Grant | A | 0.00 | 72,375 | 0 | 72,375 | 0 to 72.4 K |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Payment of Exercise | F | 21.54 | 74,657 | 1,608,112 | 774,621 | 849.3 K to 774.6 K (-8.79 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Grant | A | 0.00 | 168,521 | 0 | 849,278 | 680.8 K to 849.3 K (+24.75 %) |
| Feb 05 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Sell | S | 23.20 | 1,335 | 30,972 | 28,867 | 30.2 K to 28.9 K (-4.42 %) |
| Feb 05 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Sell | S | 23.25 | 2,000 | 46,500 | 30,202 | 32.2 K to 30.2 K (-6.21 %) |
| Feb 05 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Sell | S | 23.11 | 5,500 | 127,087 | 32,202 | 37.7 K to 32.2 K (-14.59 %) |
| Feb 01 2019 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | A | 0.00 | 27,260 | 0 | 27,260 |